MIRATON Capsule Ref.[28277] Active ingredients: Loperamide

Source: Υπουργείο Υγείας (CY)  Revision Year: 2020  Publisher: Codal-Synto Ltd, 21 Constantinoupoleos , 3011 Limassol, Cyprus

Product name and form

Miraton 2mg capsules.

Pharmaceutical Form

Capsule.

Dark green-grey hard gelatine capsules size “4”.

For oral administration.

Qualitative and quantitative composition

Each capsule contains loperamide hydrochloride 2mg.

Excipients with known effect: lactose monohydrate.

Each capsule contains 134mg lactose monohydrate.

Active Ingredient Description
Loperamide

By binding to opiate receptors in the gut wall, loperamide hydrochloride reduces propulsive peristalsis, increases intestinal transit time and enhances resorption of water and electrolytes. Loperamide increases the tone of the anal sphincter, which helps reduce faecal incontinence and urgency.

List of Excipients

Miraton also contain lactose monohydrate, pregelatinized maize starch, talc and magnesium stearate. The capsule shell contains gelatin, sunset yellow (E110), brilliant blue (E133), erythrosine (E127), and titanium dioxide (E171).

Pack sizes and marketing

Blister boxes with 10 capsules.

Marketing authorization holder

Codal-Synto Ltd, 21 Constantinoupoleos , 3011 Limassol, Cyprus

Marketing authorization dates and numbers

21061

22/08/2011 / 16/12/2020

Drugs

Drug Countries
MIRATON Cyprus, Hong Kong

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.